Drug
Organoid-guided treatment
Organoid-guided treatment is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph phase_2
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
2(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Not yet recruiting3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 22 (100.0%)
Trials by Status
not_yet_recruiting375%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruiting
Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.
NCT06615830
not_yet_recruitingphase_2
Organoids for Bile Leaks
NCT07214649
recruitingphase_2
Organoid-based Functional Precision Therapy for Advanced Breast Cancer
NCT06102824
not_yet_recruiting
Innovative Therapeutic Treatments to Inhibit Perineural Invasion in Pancreatic Adenocarcinoma
NCT06616688
Clinical Trials (4)
Showing 4 of 4 trials
NCT06615830
Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.
NCT07214649Phase 2
Organoids for Bile Leaks
NCT06102824Phase 2
Organoid-based Functional Precision Therapy for Advanced Breast Cancer
NCT06616688
Innovative Therapeutic Treatments to Inhibit Perineural Invasion in Pancreatic Adenocarcinoma
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4